RadNet
RDNT
68.61
-1.67
-2.38%
RadNet
US · RDNT
#2019 by market cap
Listed 1970
68.61
-1.67
-2.38%
Live - 5344 symbols - heartbeat 470s ago
· 2026-10-07 19:54
After-hours
68.61
0.00%
- Market cap
- 5.40B
- P/E (TTM)i
- -263.88
- P/Bi
- 4.93
- EPSi
- -0.25
- Div yieldi
- 0.00%
- 52W posi
- 51%
Reader sentiment
Are you bullish or bearish on RDNT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.07, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +11.51% YoY
Margins
- Gross margin
- 11.54%
- Operating margin
- 4.09%
- Net margin
- -0.91%
Key ratios & quality
- Enterprise valuei
- 5.78B
- Altman Z-Scorei
- 2.07
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 975.15M | 1.15B | 1.07B | 1.32B | 1.43B | 1.62B | 1.83B | 2.04B |
| Gross profit | 107.60M | 154.49M | 105.94M | 191.80M | 165.72M | 221.39M | 249.12M | 235.49M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 34.70M | 73.88M | 45.41M | 104.22M | 49.84M | 93.00M | 111.28M | 83.36M |
| Pretax profit | 38.53M | 29.67M | -854.00K | 58.88M | 42.97M | 38.81M | 44.86M | 31.91M |
| Tax | 394.00K | 6.23M | 895.00K | 14.56M | 9.36M | 8.47M | 6.03M | 14.86M |
| Net profit | 38.13M | 23.44M | -1.75M | 44.32M | 33.61M | 30.34M | 38.84M | 17.05M |
| Basic EPS | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.66 | 0.29 | -0.29 | 0.46 | 0.17 | 0.05 | 0.04 | -0.25 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 471.40M | 498.23M | 522.87M | 547.71M | 575.63M | 622.72M |
| Gross profit | 17.92M | 69.15M | 72.49M | 75.93M | 25.12M | 88.08M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -17.56M | 33.15M | 32.69M | 35.08M | -19.85M | 42.55M |
| Pretax profit | -33.14M | 23.85M | 20.27M | 20.92M | -32.83M | 26.62M |
| Tax | -3.40M | 820.00K | 6.39M | 11.06M | -8.10M | 6.36M |
| Net profit | -29.74M | 23.03M | 13.89M | 9.86M | -24.73M | 20.25M |
| Basic EPS | -1 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.51 | 0.19 | 0.07 | -0.01 | -0.43 | 0.10 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 208.69M | 241.17M | 270.42M | 324.26M | 367.18M | 579.28M | 1.02B | 1.03B |
| Cash & ST investments | 10.39M | 40.17M | 102.02M | 134.61M | 127.83M | 342.57M | 740.02M | 767.22M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.11B | 1.65B | 1.79B | 2.06B | 2.43B | 2.69B | 3.29B | 3.76B |
| Total current liabilities | 239.52M | 327.43M | 398.11M | 374.78M | 466.72M | 437.45M | 479.71M | 586.76M |
| Short-term debt | 39.27M | 104.18M | 108.16M | 76.62M | 70.01M | 73.96M | 81.31M | 87.36M |
| Long-term debt | 626.51M | 652.70M | 612.91M | 743.50M | 839.34M | 812.07M | 991.57M | 1.06B |
| Total liabilities | 909,077,000.00 | 1,413,847,000.00 | 1,528,354,000.00 | 1,712,317,000.00 | 1,942,455,000.00 | 1,877,114,000.00 | 2,153,280,000.00 | 2,402,677,000.00 |
| Total equity | 200.25M | 233.14M | 258.30M | 346.16M | 491.45M | 813.36M | 1.13B | 1.36B |
| Retained earnings | -117.92M | -103.16M | -118.00M | -93.27M | -82.62M | -79.58M | -76.79M | -95.44M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.02B | 1.09B | 1.08B | 1.03B | 740.78M | 1.04B |
| Cash & ST investments | 717.32M | 833.15M | 804.72M | 767.22M | 455.34M | 726.27M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 3.34B | 3.51B | 3.67B | 3.76B | 3.89B | 4.23B |
| Total current liabilities | 505.40M | 546.21M | 574.91M | 586.76M | 635.63M | 697.82M |
| Short-term debt | 82.57M | 85.02M | 85.79M | 87.36M | 93.10M | 100.23M |
| Long-term debt | 985.45M | 1.08B | 1.07B | 1.06B | 1.06B | 1.30B |
| Total liabilities | 2,199,747,000.00 | 2,335,705,000.00 | 2,351,320,000.00 | 2,402,677,000.00 | 2,532,677,000.00 | 2,832,300,000.00 |
| Total equity | 1.14B | 1.18B | 1.31B | 1.36B | 1.35B | 1.39B |
| Retained earnings | -114.71M | -100.26M | -94.84M | -95.44M | -128.90M | -121.37M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 116.75M | 104.32M | 233.76M | 149.49M | 146.42M | 220.86M | 233.02M | 298.82M |
| Depreciation & amortization | 72.90M | 147.45M | 154.71M | 170.66M | 184.72M | 189.49M | 198.39M | 211.99M |
| Free cash flow | 44.57M | 30.17M | 139.59M | 6.49M | 26.97M | 44.26M | 44.95M | 85.57M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | 0 | 245.83M | 218.39M | 0 |
| Ending cash balance | 10.39M | 40.17M | 102.02M | 134.61M | 127.83M | 342.57M | 740.02M | 767.22M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 41.48M | 120.35M | 52.83M | 84.16M | 78.97M | 94.10M |
| Depreciation & amortization | 35.48M | 35.99M | 39.80M | 100.72M | 44.97M | 45.53M |
| Free cash flow | -7.35M | 67.41M | -7.62M | 33.13M | 9.04M | 37.82M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 717.32M | 833.15M | 804.72M | 767.22M | 455.34M | 726.27M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 34.17 | 10.58 | -9.35 | 12.53 | 3.79 | 0.63 | 0.36 | -1.87 |
| ROA %i | 3.26 | 1.07 | -0.86 | 1.29 | 0.47 | 0.12 | 0.09 | -0.53 |
| ROIC %i | 10.24 | 4.94 | 1.39 | 4.13 | 2.90 | 2.69 | 3.03 | 1.31 |
| 5-year avg ROE %i | 28.97 | 20.66 | 10.67 | 9.61 | 10.34 | 3.64 | 1.59 | 3.09 |
| EBIT margin %i | 8.41 | 6.73 | 4.20 | 8.19 | 6.56 | 6.39 | 6.82 | 4.99 |
| FCF / sales %i | 4.57 | 2.61 | 13.02 | 0.49 | 1.89 | 2.74 | 2.46 | 4.19 |
| Current ratioi | 0.87 | 0.74 | 0.68 | 0.87 | 0.79 | 1.32 | 2.12 | 1.76 |
| Quick ratioi | 0.67 | 0.60 | 0.60 | 0.73 | 0.67 | 1.22 | 2.02 | 1.67 |
| Debt / assetsi | 60.60 | 71.71 | 66.32 | 67.90 | 62.18 | 55.42 | 52.60 | 49.46 |
| LT debt / equityi | 497.71 | 709.95 | 649.65 | 577.17 | 433.48 | 224.70 | 182.59 | 162.54 |
| Interest coveragei | 1.89 | 1.62 | 0.98 | 2.21 | 1.85 | 1.60 | 1.56 | 1.46 |
| Revenue CAGR (3Y) %i | 6.40 | 9.27 | 5.14 | 10.48 | 7.41 | 14.68 | 11.64 | 12.57 |
| Net income CAGR (3Y) %i | 61.12 | 26.85 | -- | -8.47 | -10.30 | -- | -51.66 | -- |
| FCF CAGR (3Y) %i | 22.80 | -2.34 | 19.95 | -47.40 | -3.67 | -31.81 | 90.65 | 46.95 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -3.65 | -1.65 | -1.30 | -1.87 | -1.43 | -2.08 |
| ROA %i | -1.03 | -0.44 | -0.37 | -0.53 | -0.39 | -0.55 |
| ROIC %i | 1.25 | 1.78 | 1.59 | 1.31 | 1.20 | 0.72 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.76 | 4.96 | 4.88 | 4.99 | 4.78 | 4.68 |
| FCF / sales %i | 4.17 | 3.98 | 2.64 | 4.19 | 4.75 | 3.19 |
| Current ratioi | 2.01 | 2.00 | 1.87 | 1.76 | 1.17 | 1.48 |
| Quick ratioi | 1.88 | 1.92 | 1.79 | 1.67 | 1.06 | 1.40 |
| Debt / assetsi | 52.34 | 52.38 | 50.41 | 49.46 | 49.79 | 51.65 |
| LT debt / equityi | 185.21 | 188.35 | 166.44 | 162.54 | 170.40 | 189.99 |
| Interest coveragei | 1.10 | 1.31 | 1.38 | 1.46 | 1.46 | 1.49 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Imaging Centers is the largest reported line at 96.64% of revenue, across 3 reported segments.
- The next-largest line, Digital Health, is a distant second at 5.21% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Imaging Centers96.64%
Digital Health5.21%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.